ZOLGENSMA ITNEO Trademark

Trademark Overview


On Thursday, January 18, 2024, a trademark application was filed for ZOLGENSMA ITNEO with the United States Patent and Trademark Office. The USPTO has given the ZOLGENSMA ITNEO trademark a serial number of 79391776. The federal status of this trademark filing is REGISTERED as of Tuesday, June 17, 2025. This trademark is owned by NOVARTIS AG. The ZOLGENSMA ITNEO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and gene therapy products in the nature of injectable biological preparations for the treatment of genetic, neurological, motor neuron, and neuromuscular diseases, disorders, and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials, sold as a unit, for the treatment of spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; gene therapy preparations in the nature of biological preparations containing genetic materials, sold as a unit, for sustained survival motor neuron protein expression being for the treatment of spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis
zolgensma itneo

General Information


Serial Number79391776
Word MarkZOLGENSMA ITNEO
Filing DateThursday, January 18, 2024
Status700 - REGISTERED
Status DateTuesday, June 17, 2025
Registration Number7830491
Registration DateTuesday, June 17, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 29, 2025

Trademark Statements


Goods and ServicesPharmaceutical preparations and gene therapy products in the nature of injectable biological preparations for the treatment of genetic, neurological, motor neuron, and neuromuscular diseases, disorders, and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials, sold as a unit, for the treatment of spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; gene therapy preparations in the nature of biological preparations containing genetic materials, sold as a unit, for sustained survival motor neuron protein expression being for the treatment of spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 22, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Thursday, March 21, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, April 8, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 22, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 26, 2024APPLICATION FILING RECEIPT MAILED
Monday, April 8, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 8, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, December 16, 2024NON-FINAL ACTION WRITTEN
Monday, April 8, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 8, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, April 8, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, August 9, 2024ASSIGNED TO EXAMINER
Tuesday, December 17, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, January 3, 2025NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Wednesday, March 5, 2025NON-FINAL ACTION WRITTEN
Thursday, March 6, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, March 17, 2025EXAMINERS AMENDMENT MAILED
Tuesday, April 1, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 23, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 12, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, March 12, 2025REFUSAL PROCESSED BY MPU
Monday, March 17, 2025EXAMINERS AMENDMENT -WRITTEN
Saturday, March 29, 2025REFUSAL PROCESSED BY IB
Tuesday, April 29, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 29, 2025PUBLISHED FOR OPPOSITION
Tuesday, June 17, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, June 17, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, August 20, 2025NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, August 20, 2025NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 17, 2025FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, September 5, 2025NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB